The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Antisense RNA-Induced Reduction in Murine TIMP Levels Confers Oncogenicity on Swiss 3T3 Cells
Abstract
Mouse 3T3 cell lines capable of constitutively synthesizing an RNA complementary to the messenger RNA encoding TIMP, tissue inhibitor of metalloproteinases, were constructed by transfection with appropriate plasmid constructs. Many of the lines were down-modulated for TIMP messenger RNA levels and secreted less TIMP into the culture medium. In comparison to noninvasive, nontumorigenic controls, these cells not only were invasive in a human amnion invasion assay, but also were tumorigenic and metastatic in athymic mice. These results indicate that TIMP suppresses oncogenicity, at least in immortal murine 3T3 cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Melton, D. A., Krieg, P. A., Rebagliati, M. R., Maniatis, T., Zinn, K., & Green, M. R. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7035 · Cited by 6,324
Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade
Mignatti, P., Robbins, E., & Rifkin, D. B. (1986) · Cell · doi:10.1016/0092-8674(86)90613-6 · Cited by 746
BIOCHEMICAL INTERACTIONS OF TUMOR CELLS WITH THE BASEMENT MEMBRANE
Liotta, L. A., Nageswara Rao, C. N., & Wewer, U. M. (1986) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.55.070186.005133 · Cited by 693
Schultz, R. M., Silberman, S., Persky, B., et al. (1988) · PubMed · Cited by 311
Nakajima, M., Welch, D. R., Belloni, P., & Nicolson, G. L. (1987) · PubMed · Cited by 311
Poste, G., Doll, J., & Fidler, I. J. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.10.6226 · Cited by 301
New method for preparing large surfaces of intact human basement membrane for tumor invasion studies
Liotta, L. A., Lee, C. W., & Morakis, D. J. (1980) · Cancer Letters · doi:10.1016/0304-3835(80)90105-6 · Cited by 202
Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells
Yagel, S., Parhar, R. S., Jeffrey, J. J., & Lala, P. K. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041360309 · Cited by 196
Self-citationEdwards, D. R., Waterhouse, P. D., Holman, M. L., & Denhardt, D. T. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.22.8863 · Cited by 149
Self-citationSynthesis of collagenase and collagenase inhibitors by osteoblast-like cells in culture
Otsuka, K., Sodek, J., & Limeback, H. (1984) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1984.tb08530.x · Cited by 124
Cited by
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959
“For example, the C-terminal domain (loops 4–6) of TIMP1 binds the hemopexin domain of MMP9 more readily than it does the hemopexin domain of MMP2, whereas the C-terminal domain of TIMP2 preferentially binds the hemopexin domain of MMP2 (Murphy & Willenbrock 1995).”
BackgroundInfluentialMatrix Metalloproteinases: A Review
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., & Engler, J. A. (1993) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411930040020401 · Cited by 2,970
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
Liotta, L. A., Steeg, P. S., & Stetler-Stevenson, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90642-c · Cited by 2,720
The biochemistry and medical significance of the flavonoids
Havsteen, B. H. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00298-x · Cited by 2,672
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells
Günthert, U., Hofmann, M., Rudy, W., Reber, S., Zöller, M., Hauβmann, I., Matzku, S., Wenzel, A., Ponta, H., & Herrlich, P. (1991) · Cell · doi:10.1016/0092-8674(91)90403-l · Cited by 1,654
Metalloproteinases and their inhibitors in matrix remodeling
Matrisian, L. M. (1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90126-q · Cited by 1,605
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,588
Tumor Cell Interactions with the Extracellular Matrix During Invasion and Metastasis
Stetler-Stevenson, W. G., Aznavoorian, S., & Liotta, L. A. (1993) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.09.110193.002545 · Cited by 1,526
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Self-citationValidating matrix metalloproteinases as drug targets and anti-targets for cancer therapy
Overall, C. M., & Kleifeld, O. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1821 · Cited by 1,214
Self-citationA novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
Basset, P., Bellocq, J. P., Wolf, C., Stoll, I., Hutin, P., Limacher, J. M., Podhajcer, O. L., Chenard, M. P., Rio, M. C., & Chambon, P. (1990) · Nature · doi:10.1038/348699a0 · Cited by 1,131
Tissue Inhibitor of Metalloproteinase (TIMP-2)
Stetler-Stevenson, W. G., Krutzsch, H. C., & Liotta, L. A. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71503-2 · Cited by 895
Matrix metalloproteinases in tumor invasion and metastasis
Stamenkovic, I. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0379 · Cited by 815
Specific regulation of gene expression by antisense, sense and antigene nucleic acids
Hélène, C., & Toulmé, J.-J. (1990) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(90)90031-v · Cited by 768
Matrix metalloproteinases in tumour invasion and metastasis
Curran, S., & Murray, G. I. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199911)189:3<300::aid-path456>3.0.co;2-c · Cited by 661
Tumor interactions with the vasculature: angiogenesis and tumor metastasis
Blood, C. (1990) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(90)90014-r · Cited by 593
Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies
Folgueras, A. R., Pendas, A. M., Sanchez, L. M., & Lopez-Otin, C. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041811af · Cited by 590
Goldberg, G. I., Marmer, B. L., Grant, G. A., Eisen, A. Z., Wilhelm, S., & He, C. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8207 · Cited by 586
General mechanisms of metastasis
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971015)80:8+<1529::aid-cncr2>3.0.co;2-f · Cited by 581
Molecular Cloning and Characterization of Human Tissue Inhibitor of Metalloproteinase 4
Greene, J., Wang, M., Liu, Y. E., Raymond, L. A., Rosen, C., & Shi, Y. E. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30375 · Cited by 555
Lambert, E., Dassé, E., Haye, B., & Petitfrère, E. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2003.09.008 · Cited by 541
Goldberg, G. I., Strongin, A., Collier, I. E., Genrich, L. T., & Marmer, B. L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42873-6 · Cited by 515
Complex roles of tissue inhibitors of metalloproteinases in cancer
Jiang, Y., Goldberg, I. D., & Shi, Y. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205291 · Cited by 507
Type IV collagenases in tumor invasion and metastasis
Stetler-Stevenson, W. G. (1990) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00049520 · Cited by 502
Shapiro, S. D., Kobayashi, D. K., & Ley, T. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80459-1 · Cited by 489
Stetler-Stevenson, W. G. (2008) · Science Signaling · doi:10.1126/scisignal.127re6 · Cited by 489
Leco, K. J., Khokha, R., Pavloff, N., Hawkes, S. P., & Edwards, D. R. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37115-6 · Cited by 480
Self-citationMolecular aspects of tumor cell invasion and metastasis
Aznavoorian, S., Murphy, A. N., Stetler-Stevenson, W. G., & Liotta, L. A. (1993) · Cancer · doi:10.1002/1097-0142(19930215)71:4<1368::aid-cncr2820710432>3.0.co;2-l · Cited by 459
TIMPs: versatile extracellular regulators in cancer
Jackson, H. W., Defamie, V., Waterhouse, P., & Khokha, R. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.115 · Cited by 454
Self-citationMatrix metalloproteinases in tumor invasion: Role for cell migration
Nabeshima, K., Inoue, T., Shimao, Y., & Sameshima, T. (2002) · Pathology International · doi:10.1046/j.1440-1827.2002.01343.x · Cited by 446
The Family of Matrix Metalloproteinasesa
FREDERICK WOESSNER, J. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb24720.x · Cited by 439
Cytokine regulation of metalloproteinase gene expression
Mauviel, A. (1993) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240530404 · Cited by 432
Stetler-Stevenson, W. G., Brown, P. D., Onisto, M., Levy, A. T., & Liotta, L. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77438-3 · Cited by 422
Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues
Buck, M. R., Karustis, D. G., Day, N. A., Honn, K. V., & Sloane, B. F. (1992) · Biochemical Journal · doi:10.1042/bj2820273 · Cited by 422
MacDougall, J. R., & Matrisian, L. M. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00690603 · Cited by 419
Bernhard, E. J., Gruber, S. B., & Muschel, R. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4293 · Cited by 385
The role of proteolytic enzymes in cancer invasion and metastasis
Duffy, M. J. (1992) · Clinical & Experimental Metastasis · doi:10.1007/bf00132746 · Cited by 373
Matrix Metalloproteinase Inhibitor Development and the Remodeling of Drug Discovery
Peterson, J. T. (2004) · Heart Failure Reviews · doi:10.1023/b:hrev.0000011395.11179.af · Cited by 370
Murphy, A. N., Unsworth, E. J., & Stetler‐Stevenson, W. G. (1993) · Journal of Cellular Physiology · doi:10.1002/jcp.1041570219 · Cited by 351
Matrix metalloproteinases in cancer
Itoh, Y., & Nagase, H. (2002) · Essays in Biochemistry · doi:10.1042/bse0380021 · Cited by 309
The Regulation of Neovascularization by Matrix Metalloproteinases and Their Inhibitors
Moses, M. A. (1997) · STEM CELLS · doi:10.1002/stem.150180 · Cited by 298
Inhibition of angiogenesis by tissue inhibitor of metalloproteinase
Johnson, M. D., Kim, H. C., Chesler, L., Tsao‐Wu, G., Polverini, P. J., & Bouck, N. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041600122 · Cited by 288
Brenner, C. A., Adler, R. R., Rappolee, D. A., Pedersen, R. A., & Werb, Z. (1989) · Genes & Development · doi:10.1101/gad.3.6.848 · Cited by 283
Denhardt, D. T., Feng, B., Edwards, D. R., Cocuzzi, E. T., & Malyankar, U. M. (1993) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(93)90074-n · Cited by 269
Self-citationThe matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter
Sternlicht, M. D., Bissell, M. J., & Werb, Z. (2000) · Oncogene · doi:10.1038/sj.onc.1203347 · Cited by 256
Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation
Cmarik, J. L., Min, H., Hegamyer, G., Zhan, S., Kulesz-Martin, M., Yoshinaga, H., Matsuhashi, S., & Colburn, N. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14037 · Cited by 254
Extracellular Matrix Degradation
Alexander, C. M., & Werb, Z. (1991) · Cell Biology of Extracellular Matrix · doi:10.1007/978-1-4615-3770-0_9 · Cited by 252
Ultraviolet Modulation of Human Macrophage Metalloelastase in Human Skin In Vivo
Chung, J. H., Seo, J. Y., Lee, M. K., Eun, H. C., Lee, J. H., Kang, S., Fisher, G. J., & Voorhees, J. J. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01844.x · Cited by 163
Rivera, S., Tremblay, E., Timsit, S., Canals, O., Ben-Ari, Y., & Khrestchatisky, M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04223.1997 · Cited by 135
Antitumorigenic effects of cannabinoids beyond apoptosis.
Freimuth, N., Ramer, R., & Hinz, B. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157735 · Cited by 71
Kanazawa (1996) · doi:10.1002/(sici)1097-0142(19960415)77:8+<1701::aid-cncr18>3.0.co;2-1
Metadata
- Authors
- Khokha, R., Waterhouse, P., Yagel, S., Lala, P. K., Overall, C. M., Norton, G., & Denhardt, D. T.
- Venue
- Science
- Published
- 1989-02-17
- Volume
- 243
- Issue
- 4893
- Pages
- 947-950
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2077483002
- Cited by
- 451
- References
- 12
- FWCI
- 21.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.